Viridian Therapeutics Inc
VRDNHealthcare|Biotechnology|USA
$19.75
-0.46 (-2.28%)
Tangible Book
$4.92
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (38)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Fairmount Healthcare Fund II GP LLC | Director, 10% Owner | 2026-05-11 | BUY | 1,176,470 | $17 | $20000K |
| Tousignant Jennifer | Chief Legal Officer | 2025-12-31 | SELL | 2,272 | $31.16 | $70.8K |
| Fairmount Healthcare Fund II GP LLC | Director, 10% Owner | 2025-10-23 | BUY | 454,545 | $22 | $10000K |
| Beetham Thomas W. | COO | 2024-09-27 | BUY | 5,000 | $23.41 | $117.1K |
| Mahoney Stephen F. | President and CEO | 2024-09-27 | BUY | 21,400 | $23.33 | $499.3K |
| Fairmount Healthcare Fund II GP LLC | Director, 10% Owner | 2024-09-13 | BUY | 1,600,000 | $18.75 | $30000K |
| Fairmount Healthcare Fund GP LLC | 2024-01-22 | BUY | 476,190 | $21 | $10000K | |
| Meisner Lara | Chief Legal Officer | 2023-06-16 | SELL | 2,296 | $28.02 | $64.3K |
| Meisner Lara | Chief Legal Officer | 2023-06-06 | SELL | 7,500 | $24.82 | $186.2K |
| Myers Scott Dunseth | CEO | 2023-04-12 | BUY | 4,000 | $25.37 | $101.5K |
| Myers Scott Dunseth | CEO | 2023-03-13 | BUY | 5,500 | $29.15 | $160.3K |
| Meisner Lara | General Counsel and Secretary | 2023-03-09 | SELL | 29,971 | $29.07 | $871.3K |
| Violin Jonathan | Chief Executive Officer | 2023-02-02 | SELL | 50,000 | $36.8 | $1840K |
| Violin Jonathan | Chief Executive Officer | 2023-02-02 | SELL | 50,000 | $36.8 | $1840K |
| Meisner Lara | General Counsel and Secretary | 2023-01-23 | SELL | 6,843 | $35.66 | $244K |
| Katz Barrett | Chief Medical Officer | 2023-01-17 | SELL | 29,000 | $37.18 | $1078.2K |
| Katz Barrett | Chief Medical Officer | 2023-01-10 | SELL | 60,000 | $34.82 | $2089.2K |
| Meisner Lara | General Counsel and Secretary | 2022-12-21 | SELL | 16,926 | $29.15 | $493.4K |
| Meisner Lara | General Counsel and Secretary | 2022-12-16 | SELL | 1,597 | $28.37 | $45.3K |
| Meisner Lara | General Counsel and Secretary | 2022-12-14 | SELL | 16,256 | $28.12 | $457.1K |
| Meisner Lara | General Counsel and Secretary | 2022-11-15 | SELL | 8,125 | $22.05 | $179.2K |
| Fairmount Healthcare Fund GP LLC | Director, 10% Owner | 2022-08-17 | BUY | 425,531 | $23.5 | $10000K |
| Violin Jonathan | Chief Executive Officer | 2022-06-01 | SELL | 30,000 | $12.2 | $366K |
| Violin Jonathan | CEO | 2022-05-02 | SELL | 30,000 | $13.04 | $391.2K |
| Violin Jonathan | Chief Executive Officer | 2022-04-04 | SELL | 30,000 | $18.92 | $567.6K |
| Violin Jonathan | Chief Executive Officer | 2022-02-03 | SELL | 30,000 | $19.09 | $572.7K |
| Frazier Life Sciences Public F | 10% Owner | 2021-09-23 | BUY | 200,000 | $11 | $2200K |
| Fairmount Healthcare Fund GP L | 2021-09-21 | BUY | 909,000 | $11 | $9999K | |
| Logos Global Master Fund LP | 10% Owner | 2020-11-13 | BUY | 476,667 | $4.76 | $2268.9K |
| Hughes Thomas E. | Director | 2018-10-11 | BUY | 667 | $71.55 | $47.7K |
| Levy Adam Scott | Chief Business Officer | 2018-02-13 | BUY | 606 | $82.5 | $50K |
| Booth Bruce | Director | 2018-02-13 | BUY | 36,364 | $82.5 | $3000K |
| Hughes Thomas E. | Director | 2017-12-20 | SELL | 800 | $120 | $96K |
| Levy Adam Scott | Chief Business Officer | 2017-06-22 | BUY | 13 | $113.25 | $1.5K |
| LEFKOFF KYLE | Director | 2017-03-10 | SELL | 387 | $215.1 | $83.2K |
| LEFKOFF KYLE | Director | 2017-03-08 | SELL | 1,000 | $231 | $231K |
| LEFKOFF KYLE | Director | 2017-02-28 | SELL | 684 | $208.35 | $142.5K |
| LEFKOFF KYLE | Director | 2017-02-23 | SELL | 393 | $212.1 | $83.5K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked